The hypertension peril and drug development.
Somberg
John
J
D000924:Anticholesteremic Agents / Q000009:adverse effects; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects; D004345:Drug Industry / Q000458:organization & administration*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D011804:Quinolines / Q000009:adverse effects
D000924:Anticholesteremic Agents; D052246:Cyclooxygenase 2 Inhibitors; D011804:Quinolines; C483909:torcetrapib